Since our last report on BioMarin Pharmaceutical in late December, shares of the San Rafael, Calif., based company have solidly outperformed the broader biotechnology sector, rallying over 21% compared to around 13% for the Nasdaq Biotechnology Index.
http://seekingalpha.com/article/1298411-biomarin-gains-to-continue-as-pipeline-progress-is-realized?source=feed
http://seekingalpha.com/article/1298411-biomarin-gains-to-continue-as-pipeline-progress-is-realized?source=feed
No comments:
Post a Comment